FourThought Financial Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
FourThought Financial Partners's PFE Position: Q1 2026 in Review
FourThought Financial Partners reduced its Pfizer (PFE) stake by 12% in Q1 2026, selling an estimated $65.7K and leaving 17,309 shares worth $486K. The position accounts for 0.04% of the portfolio, ranked #188.
FourThought Financial Partners first reported a position in PFE in Q4 2022 and has held it in 12 quarters since. The position peaked at $1.56M in Q4 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- FourThought Financial Partners held 17,309 shares of Pfizer worth $486K as of Q1 2026.
- FourThought Financial Partners sold 2,468 Pfizer shares in Q1 2026, an estimated $65.7K.
- Pfizer made up 0.04% of FourThought Financial Partners's portfolio in Q1 2026, its #188 holding.
- FourThought Financial Partners first reported a position in Pfizer in Q4 2022 and has held it in 12 quarters since.
- FourThought Financial Partners's Pfizer position peaked at $1.56M in Q4 2022.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on FourThought Financial Partners's 13F filing for Q1 2026, filed 7 May 2026.